Shalev A, Holst JJ, Keller U
Lawsuit alleges Iowa telepharmacy sold fake Ozempic to Michigan company Fake GLP-1 medications including Ozempic are becoming a national problem and pose a health risk, experts say
During the 5-day navigation phase of the MWM test, all the mice tended to have shorter escape time and distance
Clinical trials across autoimmune diseases indicate a potential role for metformin as an adjunct therapy
Kuo YM, Hsu PC, Hung CC, Hu YY, Huang YJ, Gan YL, et al
New @Nature A quintuple [GLP-1 + 4 other] receptor agonist drug that exceeds effects of the dual receptor (GLP-1 and GIP, tirzepatide) in the experimental model vs diabetes and obesity (in case you thought a dual receptor was max effect, as also seen with retatrutide, a triple pic.twitter.com/bvjCbj5Y6P - Eric Topol (@EricTopol) April 29, 2026 Journal reference: Liskiewicz, D., Novikoff, A., Khalil, A